Increased Cytokines Response in Patients with Tuberculosis Complicated with Chronic Obstructive Pulmonary Disease

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Tang, Shenjie ^a,b   Cui, Haiyan ^b   Yao, Lan ^b   Hao, Xiaohui ^b   Shen, Yun ^b   Fan, Lin ^b   Sun, Hua ^b   Zhang, Zhanjun ^b   Huang, Jian An ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE RECEPTOR;

ADULT; ARTICLE; CD4 CD8 RATIO; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CORRELATIONAL STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN CELL; LUNG TUBERCULOSIS; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; UPREGULATION; AGED; BLOOD; CD4 LYMPHOCYTE COUNT; COMPLICATION; IMMUNOLOGY; METABOLISM; MIDDLE AGED; RISK FACTOR;

ADULT; AGED; CD4 LYMPHOCYTE COUNT; CD4-CD8 RATIO; CYTOKINES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEPTORS, CYTOKINE; RISK FACTORS; TUBERCULOSIS, PULMONARY;

EID: 84876544174     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062385     Document Type: Article

References (44)

1. World Health Organization (2008) Global tuberculosis control: surveillance, planning, financing. WHO Report 2008.WHO/HTM/TB/2008.393.
2. Calverley PM, Walker P, (2003) Chronic obstructive pulmonary disease. Lancet 362: 1053-1061.
3. Inghammar M, Ekbom A, Engström G, Ljungberg B, Romanus V, et al. (2010) COPD and the Risk of Tuberculosis- A Population-Based Cohort Study. PLoS ONE 5(4): e10138.
4. Liu CH, Yang N, Wang Q, Hu YL, Li L, et al. (2011) Risk factors associated with fluoroquinolone-resistant tuberculosis in a Beijing tuberculosis referral hospital. Respirology 16: 918-925.
5. Rajavelu P, Das SD, (2005) Th2-type immune response observed in healthy individuals to sonicate antigen prepared from the most prevalent Mycobacterium tuberculosis strain with single copy of IS6110. FEMS Immunol Med Microbiol 45: 95-102.
6. Katti MK, (2011) Assessment of serum IL-1, IL-2 and IFN-γ levels in untreated pulmonary tuberculosis patients: role in pathogenesis. Arch Med Res 42(3): 199-201.
7. GOLD (2010) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Available: http://www.goldcopd.com.
8. Kellar KL, Gehrke J, Weis SE, Mahmutovic-Mayhew A, Davila B, et al. (2011) Multiple cytokines are released when blood from patients with tuberculosis is stimulated with Mycobacterium tuberculosis antigens. PLoS One 6(11): e26545.
9. Chen CY, Huang D, Wang RC, Shen L, Zeng G, et al. (2009) A critical role for CD8 T cells in a nonhuman primate model of tuberculosis. PLoS Pathogens 5: e1000392.
10. Elvang T, Christensen JP, Billeskov R, Thi Kim Thanh Hoang T, Holst P, et al. (2009) CD4 and CD8 T cell responses to the M. tuberculosis Ag85B-TB10.4 promoted by adjuvanted subunit, adenovector or heterologous prime boost vaccination. PLoS One 4(4): e5139.
11. Kiran B, Cagatay T, Clark P, Kosar F, Cagatay P, et al. (2010) Can immune parameters be used as predictors to distinguish between pulmonary multidrug-resistant and drug-sensitive tuberculosis? Arch Med Sci 6(1): 77-82.
12. Koch A, Gaczkowski M, Sturton G, Staib P, Schinköthe T, et al. (2007) Modification of surface antigens in blood CD8+ T-lymphocytes in COPD: effects of smoking. Eur Respir J 29(1): 42-50.
13. Kim WD, Kim WS, Koh Y, Lee SD, Lim CM, et al. (2002) Abnormal peripheral blood T-lymphocyte subsets in a subgroup of patients with COPD. Chest, 122 (2): 437-444.
14. Paats MS, Bergen IM, Hoogsteden HC, van der Eerden MM, Hendriks RW, (2012) Systemic CD4+ and CD8+ T-cell cytokine profiles correlate with GOLD stage in stable COPD. Eur Respir J 40(2): 330-7.
15. Mueller H, Detjen AK, Schuck SD, Gutschmidt A, Wahn U, et al. (2008) Mycobacterium tuberculosis-specific CD4+, IFNgamma+, and TNFalpha+ multifunctional memory T cells coexpress GM-CSF. Cytokine 43(2): 143-148.
16. Küpeli E, Karnak D, Beder S, Kayacan O, Tutkak H, (2008) Diagnostic accuracy of cytokine levels (TNF-alpha, IL-2 and IFN-gamma) in bronchoalveolar lavage fluid of smear-negative pulmonary tuberculosis patients. Respiration 75(1): 73-78.
17. Al-Attiyah R, El-Shazly A, Mustafa AS, (2012) Comparative analysis of spontaneous and mycobacterial antigen-induced secretion of Th1, Th2 and pro-inflammatory cytokines by peripheral blood mononuclear cells of tuberculosis patients. Scand J Immunol 75(6): 623-632.
18. Cava F, Gonzalez C, Pascual MJ, Navajo JA, Gonzalez-Buitrago JM, (2000) Biological variation of inter-leukin 6 (IL-6) and soluble interleukin 2 receptor (sIL2R) in serum of healthy individuals. Cytokine 12: 1423-1425.
19. Shitrit D, Izbicki G, Bar-Gil Shitrit A, Raz M, Sulkes J, et al. (2006) Role of soluble interleukin-2 receptor levels in patients with latent tuberculosis. Lung 184 (1): 21-24.
20. Barnes PJ, (2009) The Cytokine Network in Chronic Obstructive Pulmonary Disease. Am J Respir Cell Mol Biol 41: 631-638.
21. GadgilA, Zhu X, Sciurba FC, Duncan SR, (2006) Altered T-cell phenotypes in chronic obstructive pulmonary disease. Proc Am Thorac Soc 3 (6): 487-488.
22. Curtis JL, Freeman CM, Hogg JC, (2007) The immunopathogenesis of chronic obstructive pulmonary disease: insights from recent research. Proc Am Thorac Soc 4 (7): 512-521.
23. Tsao TC, Huang CC, Chiou WK, Yang PY, Hsieh MJ, et al. (2002) Levels of interferon-gamma and interleukin-2 receptor-alpha for bronchoalveolar lavage fluid and serum were correlated with clinical grade and treatment of pulmonary tuberculosis. Int J Tuberc Lung Dis 6(8): 720-727.
24. Mattos AM, Almeida Cde S, Franken KL, (2010) Increased IgG1, IFN-gamma, TNF-alpha and IL-6 responses to Mycobacterium tuberculosis antigens in patients with tuberculosis are lower after chemotherapy. Int Immunol 22(9): 775-782.
25. Donaldson GC, Seemungal TA, Patel IS, Bhowmik A, Wilkinson TM, et al. (2005) Airway and systemic inflammation and decline in lung function in patients with COPD. Chest 128: 1995-2004.
26. He JQ, Foreman MG, Shumansky K, Zhang X, Akhabir L, et al. (2009) Associations of IL-6 polymorphisms with lung function decline and COPD. Thorax 64: 698-704.
27. Karadag F, Karul AB, Cildag O, Yilmaz M, Ozcan H, (2008) Biomarkers of systemic inflammation in stable and exacerbation phases of COPD. Lung 186: 403-409.
28. Yende S, Waterer GW, Tolley EA, Newman AB, Bauer DC, et al. (2006) Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjects. Thorax 61: 10-16.
29. Djoba Siawaya JF, Beyers N, van Helden P, Walzl G, (2009) Differential cytokine secretion and early treatment response in patients with pulmonary tuberculosis. Clin Exp Immunol 156: 69-77.
30. Kaufmann SHE, (2001) How can immunology contribute to the control of tuberculosis? Nature Reviews Immunology 1(1): 20-30.
31. Nemeth J, Winkler HM, Boeck L, Adegnika AA, Clement E, et al. (2011) Specific cytokine patterns of pulmonary tuberculosis in Central Africa. Clin Immunol 138(1): 50-59.
32. Sutherland JS, de Jong BC, Jeffries DJ, Jeffries DJ, Adetifa IM, et al. (2010) Production of TNF-alpha, IL-12(p40) and IL-17 can discriminate between active TB disease and latent infection in a West African cohort. PLoS One 5(8): e12365.
33. Bekker LG, Moreira AL, Bergtold A, Freeman S, Ryffel B, et al. (2000) Immunopathologic effects of tumor necrosis factor alpha in murine mycobacterial infection are dose dependent. Infect. Immun 68: 6954-6961.
34. Moermans C, Heinen V, Nguyen M, Henket M, Sele J, et al. (2011) Local and systemic cellular inflammation and cytokine release in chronic obstructive pulmonary disease. Cytokine 56(2): 298-304.
35. Lago PM, Boéchat N, Migueis DP, Almeida AS, Lazzarini LC, et al. (2012) Interleukin-10 and interferon-gamma patterns during tuberculosis treatment: possible association with recurrence. Int J Tuberc Lung Dis 16(5): 656-659.
36. Ray JC, Wang J, Chan J, Kirschner DE, (2008) The timing of TNF and IFN-gamma signaling affects macrophage activation strategies during Mycobacterium tuberculosis infection. J Theor Biol 252(1): 24-38.
37. Barnes PJ, (2009) The cytokine network in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 41: 631-638.
38. Katti MK, (2012) Assessment of serum IL-1, IL-2 and IFN-γ levels in untreated pulmonary tuberculosis patients: role in pathogenesis. Arch Med Res 42 (3): 199-201.
39. Jurado JO, Pasquinelli V, Alvarez IB, Pena D, Rovetta AI, (2012) IL-17 and IFN-γ expression in lymphocytes from patients with active tuberculosis correlates with the severity of the disease. J Leukoc Biol 91(6): 991-1002.
40. Zhang SJ, Xiao HP, (2011) Changes and significance of peripheral blood T cell subsets, soluble interleukin-2 receptor and interferon-gamma in patients with retreatment pulmonary tuberculosis and initial treatment tuberculosis. Zhonghua Jie He He Hu Xi Za Zhi 34(12): 884-887.
41. Aaron SD, Angel JB, Lunau M, Wright K, Fex C, et al. (2001) Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 163: 349-355.
42. Bucchioni E, Kharitonov SA, Allegra L, Barnes PJ, (2003) High levels of interleukin-6 in the exhaled breath condensate of patients with COPD. Respir Med 97: 1299-1302.
43. Soler N, Ewig S, Torres A, Filella X, Gonzalez J, et al. (1999) Airway inflammation and bronchial microbial patterns in patients with stable COPD. Eur Respir J 14 (5): 1015-1022.
44. Herfs M, Hubert P, Poirrier AL, Vandevenne P, Renoux V, et al. (2012) Proinflammatory cytokines induce bronchial hyperplasia and squamous metaplasia in smokers: implications for chronic obstructive pulmonary disease therapy. Am J Respir Cell Mol Biol 47(1): 67-79.